Insmed
Insmed Employee Spotlight: David Cipolla
5:02
Latest read on rare disease gene therapy from Insmed CEO Will Lewis
1:42
Insmed Employee Spotlight: Kush Patel
5:25
Insmed: How We Approach Gene Therapy
1:31
A Day in the Life at Insmed – Samuel, Therapeutic Specialist
5:07
Insmed CEO on what’s next for company after FDA greenlights lung disease drug
8:44
Insmed Aktie Analyse 2026: Durchbruch bei Brinsupri & Arikayce – Jetzt Kaufen?
1:50
Insmed Employee Spotlight: Claire Godbersen-Palmer
1:31
Insmed: We’re in. For whatever challenge comes next.
8:09
Insmed (INSM) stock: RISKY SETUP — 67% revenue growth
5:23
Insmed CEO Will Lewis talks its rare disease drug pipeline
11:20
Der 1-Milliarden-Mic-Drop! 🎤 Warum INSMED (INSM) jetzt explodiert 💥
5:16
Insmed CEO on lung disease treatment and path forward
4:24
Insmed 2026 Second Quarter Performance and Investor Presentation (INSM)
6:25
My Take on Insmed's Brensocatib Trial Setback
2:03
Insmed Employee Spotlight: Bobby Tarantino